Projects

InOpSys

Sector
Circular Economy
Line of Business
Flexible and mobile units for wastewater treatment
Founders
AvOre (Steven De Laet) and Raf De Wil
Registered Office
12A Zandvoortstraat,
2800 Mechelen

InOpsys develops and builds flexible, modular and mobile units for onsite toxic wastewater treatment. This unique concept combines expertise, the use of existing and clean technologies as well as a new approach to waste management. In this way, InopSys helps chemical and pharmaceutical industries to reach their sustainable development goals.

The expertise comes from the KU Leuven, the technologies are acquired on the market or developed by AvoRe (one of the founders of InOpSys). The innovative approach consists of bringing the installation to the location where the water has to be treated by truck (Plant-On-A-Truck).

For more information: InOpSys

Innovation Fund Investment

On 18 December 2015, the Innovation Fund and Gemma Frisius invested EUR 500,000 each in InOpSys. An additional investment is planned for 2017 depending on the completion of certain intermediate steps.

Lisam

Sector
Processes, Information Technology
Line of Business
Management services for legal documents and reports on the environment, health and safety for different industrial sectors including chemistry.
Founders
Thierry Levintoff and Michel Hemberg
Registered Office
42A Boulevard de la Sennette,
7190 Ecausinnes

Combining a flexible technology that is easy to use, based on the Microsoft .NET platform with the latest regulatory content, Lisam provides innovative, affordable and rapid solutions to the environment, health and safety (EHS) challenges faced by manufacturers, distributors and users of chemical and cosmetic products.

In cooperation with the associations and partners from industry, Lisam has developed proprietary and vertical EHS solutions for chemicals, chemical speciality products, cosmetics, aromas, detergents, paints, coatings, plastics and the energy industries. Today, more than 900 customers in industry count on the Lisam flagship software, ExeSS®, to manage their safety datasheets and their labels, designed for all the main commercial markets and available in 50 languages.

For more information: Lisam

Innovation Fund Investment

On 28 January 2016, the Innovation Fund invested EUR 250,000 in LISAM.

PharmaFluidics

Sector
Processes – molecular separation and analysis
Line of Business
New generation liquid chromatography column
Founders
Paul Jacobs, Wim De Malssche, Gert Desmet and Joeri Denayer
Registered Office
Technologiepark, 3 Zwijnaarde,
9052 Zwijnaarde

PharmaFluidics is a spin-off of the Dutch-speaking Free University of Brussels (VUB) and has benefited from initial PMV/SOFI and Qbic financing to the tune of EUR 1.25 million.
The company has developed a new type of liquid chromatography columns (in the field of mixture separation and analysis) which shows a significant advantage compared to existing columns: facility of use, standardisation, efficacy and potential development to measure.

The company aspires to refine these columns further, obtain additional recommendations from laboratories and opinion leaders in the field, and market them in the biotech, pharmaceutical and chemical industries.

For more information: PharmaFluidics

Innovation Fund Investment

On 9 May 2016, the Innovation Fund invested EUR 199,992 in PharmaFluidics. Further investments were made in 2017 and are expected going forward. The Fund’s stake in the capital is 9.63%

TrendMiner

Sector
Processes, Information Technology
Line of Business
Industrial process analysis, monitoring and prediction application
Founders
Bert Baeck, Noël Jans, Thomas Dhollander and Tom Coen
Registered Office
297 Kempische Steenweg B3,
B-3500 Hasselt

TrendMiner has developed an application which analyses and monitors in real time the temporal series of production parameters. TrendMiner is used to predict certain production anomalies by relying on the (predictive) recognition of historical patterns and search of similar historical patterns to help explain the causes of production deviances. TrendMiner “learns” by relying on parameters provided by the operator.

For more information: TrendMiner

Innovation Fund Investment

On 10 May 2016, the Innovation Fund decided to invest EUR 1,000,000 in TrendMiner.

X4C

Sector
Materials Technology
Line of Business
Application of a single layer in calix (4) arene for post-functionalisation.
Founders
Alice Mattiuzzi
Registered Office
(French-speaking) Free University of Brussels (ULB)
Organic Chemistry Laboratory
50 Avenue Franklin Roosevelt CP160/06
B-1050 Brussels

X4C has developed a new technology for applying a single layer on a substrate and for the post-functionalising of the substrate. This concept leads to a strong covalent bond between the substrate and the functional element.

The technology was developed in the organic chemistry laboratory of the Free University of Brussels under the direction of Professor Ivan Jabin.

For more information: X4C

Innovation Fund Investment

On 18 March 2016, the Innovation Fund decided to invest EUR 30,000 in X4C. This investment is contingent upon the finalisation of the licensing agreement with the Free University of Brussels. An additional investment is planned for 2017, depending on the results of the first commercial steps.

Fyteko

Sector
Biosciences
Line of Business
Development of a bio-stimulant to foster resistance to abiotic stress in crops
Founders
Juan Carlos Cabrera Pino, Guillaume Wegria
Registered Office
Clos Chapelle-aux-Champs 30
1200 Bruxelles

Fyteko has discovered a molecule that induces better resistance to abiotic stress in a number of crops.

The scientific research was carried out by the founders.

For more information: Fyteko

Innovation Fund Investment

On September 29th, 2016, the Innovation Fund invested in Fyteko. The investment will help Fyteko register and market its first molecule while encouraging further research into formulation and molecules.

Mathym

Sector
Materials Technology
Line of Business
Nanomaterials in colloidal solutions
Founders
Frederic Chaput, Julien Alberici
Registered Office
22 rue des Aulnes
69410 Champagne-au-Mont-d’Or
France

Mathym has developed a technology to produce easy and safe to use nanoparticles as ingredients in medical composite materials. The first products will be commercialized in 2017.

The underlying research was carried out by Frederic Chaput at ENS Lyon and Essilor.

For more information: Mathym

Innovation Fund Investment

The Innovation Fund invested alongside Octalfa, Kreaxi and two business angels to support the industrialization of the technology and the marketing of Mathym’s first product

Aerosint

Sector
Materials Technology
Line of Business
3D Printing/additive manufacturing
Founders
M4ke.it, Matthias Hick, Edouard Moens, Kevin Eckes
Registered Office
Rue des Poles 1
4000 Liege
Belgium

Aerosint is working on an industrial prototype that improves the material efficiency of SLS 3D printing. Aerosint aims to have the prototype ready for licensing in 2018.

For more information: Aerosint

Innovation Fund Investment

The Innovation Fund invested alongside Meusinvest to support the move from proof of concept to industrial prototype.

Proceedix

Sector
Processes, Information Technology
Line of Business
Procedures, work instructions and checks made paperless and mobile
Founders
Peter Verstraeten, Steven Serneels
Registered Office
Ottergemsesteenweg Zuid, 808
Ghelamco Arena - Meet District
9000 Ghent

Proceedix develops, markets and sells a solution to enable procedures, work instructions and checks to be carried out paperless and mobile. The software allows to very easily transform paper instructions into a set of digital instructions. The level of details of the various steps can be adjusted by the operator according to his/her level of experience and/or comfort.

Proceedix works best as a cloud solution and is tailored for visualisation on desktops, laptops, phones, tablets or smartglasses.

For more information: Proceedix

Innovation Fund Investment

The Innovation Fund invested together with Saffelberg Investments, Pentacon and the management to fund the go to market.

Iristick

Sector
Processes, Information Technology
Line of Business
Wearables
Registered Office
Lamorinierestraat, 123
2018 Antwerpen

Iristick designs smartglasses for the industry. The Iristick qualifies as safety glasses, can be fitted with prescription glasses and allows the user to handle complex tasks while communicating hands-free, getting instant access to information and sharing data with other operators.

For more information: Iristick

Innovation Fund Investment

The Innovation Fund partnered with Saffelberg Investments, Pentacon and the management to fund the commercial launch of Iristick.

AllerInvest

Sector
Biosciences
Line of Business
Allergies
Founders
Anne-Catherine Mailleux, Pierre Buffet
Registered Office
Clos Chapelle aux Champs 30
1200 Bruxelles

Acar’Up commercialises through pharmacists a kit to prevent allergies to dustmites. The regular application of the treatment to the bedding reduces the allergic response of the patient and allows him or her to sleep much better.

For more information: Acar’up

Innovation Fund Investment

The Innovation Fund invested alongside Inventures, Theodorus and My Micro Invest to fund the commercial expansion of Acar’Up.

Blue Foot Membranes

Sector
Materials Technology
Line of Business
Back washable flat sheet membrane
Founders
Patrick Vanschoubroek, VITO
Registered Office
Gerard Mercatorstraat 31
3920 Lommel

Blue Foot Membranes is a start-up company producing and commercialising the unique and worldwide-patented Integrated Permeate Channel (IPC™) technology.
IPC™ membranes are the worlds first fully back washable flat sheet membrane. Installed in existing as well as in new membrane bioreactor, IPC™ membranes can double the output capacity per square meter and lower the aeration cost by at least 50% of your existing or future MBR.

For more information: Blue Foot Membranes

Innovation Fund Investment

The Innovation Fund invested with LRM, Qbic and Dow to finance the industrialisation of the production and the commercial roll out of the IPC™ membrane.